Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
INTEGRATED BIOPHARMA INC incurred debt of $500,000.00 with PNC Bank, National Association at Daily one-month SOFR plus 250 basis points (2.50%) maturing April 5, 2026.
- Principal
- $500,000.00
- Counterparty
- PNC Bank, National Association
- Rate
- Daily one-month SOFR plus 250 basis points (2.50%)
- Maturity
- April 5, 2026
- Event
- incurrence
Exact text from the filing
a Convertible Equipment Line of Credit in an amount in the aggregate at any time outstanding not to exceed $500,000.00 (the "Convertible ELOC")
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
INTEGRATED BIOPHARMA INC incurred revolving credit of $4,000,000.00 with PNC Bank, National Association at Daily one-month SOFR plus 250 basis points (2.50%) maturing April 5, 2026.
- Instrument
- revolving credit
- Principal
- $4,000,000.00
- Counterparty
- PNC Bank, National Association
- Rate
- Daily one-month SOFR plus 250 basis points (2.50%)
- Maturity
- April 5, 2026
- Event
- incurrence
Exact text from the filing
The Loan Agreement provides a committed revolving line of credit under which the Borrower may request and the Bank will make advances to the Borrower from time to time until April 5, 2026, (the "Expiration Date"), in an aggregate amount outstanding at any time not to exceed $4,000,000.00
View on SEC.gov